2-[4-(2H-1,3-benzodioxol-5-yl)-3-tert-butyl-1-(4-methoxyphenyl)-7-oxo-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-propylacetamide
Chemical Structure Depiction of
2-[4-(2H-1,3-benzodioxol-5-yl)-3-tert-butyl-1-(4-methoxyphenyl)-7-oxo-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-propylacetamide
2-[4-(2H-1,3-benzodioxol-5-yl)-3-tert-butyl-1-(4-methoxyphenyl)-7-oxo-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-propylacetamide
Compound characteristics
Compound ID: | V021-2910 |
Compound Name: | 2-[4-(2H-1,3-benzodioxol-5-yl)-3-tert-butyl-1-(4-methoxyphenyl)-7-oxo-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-propylacetamide |
Molecular Weight: | 550.68 |
Molecular Formula: | C29 H34 N4 O5 S |
Salt: | not_available |
Smiles: | CCCNC(CN1C(CSC(c2ccc3c(c2)OCO3)c2c(C(C)(C)C)nn(c3ccc(cc3)OC)c12)=O)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 5.1414 |
logD: | 5.1414 |
logSw: | -5.0372 |
Hydrogen bond acceptors count: | 9 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 79.54 |
InChI Key: | PPGOTFLJNORVHV-AREMUKBSSA-N |